Predicting cardiac conduction block in anti-SSA/Ro antibody-positive adults: development of a risk stratification model

Background Anti-SSA/Ro antibody positivity has been increasingly linked to cardiac conduction block (CCB), yet the clinical features and risk factors for conduction abnormalities in this population remain unclear. Unlike degenerative conduction disease, antibody-mediated conduction dysfunction may be reversible at an early stage. This study aimed to identify independent risk factors for prevalent CCB at admission in anti-SSA/Ro antibody-positive patients and to develop an individualized risk-stratification model. Methods In this single-center retrospective study, 869 adult patients with anti-SSA/Ro antibody positivity were enrolled, of whom 174 had CCB at admission, and were randomly divided into a training set ( n = 608) and an internal validation set ( n = 261) at a 7:3 ratio. Lasso regression, univariate and multivariable logistic regression were used for variable selection and model development. Discrimination was assessed by the area under the receiver operating characteristic curve (AUC), calibration by the Hosmer-Lemeshow test, and clinical utility by decision curve analysis. Based on the regression coefficients of the multivariable logistic regression model, the coefficients were simplified into an simplified risk score, and patients were stratified into low-, intermediate- and high-risk groups by the tertiles of the total score in the training set, missing values imputed separately within each set and all model parameters derived from the training set. Results Twelve variables were selected by Lasso regression, and multivariable logistic regression identified Gender (OR = 2.12, 95% CI 1.41–3.21, P < 0.001), Age (per 1-year increase: OR = 1.03, 95% CI 1.02–1.05, P < 0.001) and Heart rate (per 1-beat/min increase: OR = 0.99, 95% CI 0.97–0.99, P = 0.045) as independent predictors of prevalent CCB at admission. The AUC was 0.68 (95% CI 0.63–0.74) and 0.70 (95% CI 0.62–0.78) in the training and internal validation sets, respectively, and the corresponding Hosmer-Lemeshow P values were 0.9676 and 0.7584.In the internal validation set, the calibration intercept was −0.04 (95% CI −0.35 to 0.28) and the calibration slope 1.12 (95% CI 0.61 to 1.63). The odds of CCB increased stepwise across the low-, intermediate- and high-risk strata in both sets (intermediate risk: OR 2.54 and 2.80; high risk: OR 4.73 and 6.56, respectively). Conclusion Female Gender, Age and Heart rate were independent predictors of prevalent CCB at admission in anti-SSA/Ro antibody-positive patients. A risk score based on these three predictors stratified patients into low-, intermediate- and high-risk groups, with a stepwise increase in the odds of CCB that was reproduced in the internal validation set. Discrimination was nevertheless modest and, pending external validation, the score should serve as an adjunctive tool for preliminary risk stratification rather than for individual prediction or diagnosis.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-11-17
DOI
https://doi.org/10.3389/fcvm.2026.1987455
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Predicting cardiac conduction block in anti-SSA/Ro antibody-positive adults: development of a risk stratification model

Baopeng Tang, Wen Wang, Meidina Yeerken, Yanmei Lu et al.
Frontiers in Cardiovascular Medicine
Systemic Lupus Erythematosus Research
article

Predicting cardiac conduction block in anti-SSA/Ro antibody-positive adults: development of a risk stratification model

Baopeng Tang, Wen Wang, Meidina Yeerken, Yanmei Lu, Xingli Gu, Xianhui Zhou, Ruotong Cao, Xiaotong Liu, Meng Wei, Sicheng Xu, Zhaoxia Yu, Lijuan Feng
article en

Abstract

Background Anti-SSA/Ro antibody positivity has been increasingly linked to cardiac conduction block (CCB), yet the clinical features and risk factors for conduction abnormalities in this population remain unclear. Unlike degenerative conduction disease, antibody-mediated conduction dysfunction may be reversible at an early stage. This study aimed to identify independent risk factors for prevalent CCB at admission in anti-SSA/Ro antibody-positive patients and to develop an individualized risk-stratification model. Methods In this single-center retrospective study, 869 adult patients with anti-SSA/Ro antibody positivity were enrolled, of whom 174 had CCB at admission, and were randomly divided into a training set ( n = 608) and an internal validation set ( n = 261) at a 7:3 ratio. Lasso regression, univariate and multivariable logistic regression were used for variable selection and model development. Discrimination was assessed by the area under the receiver operating characteristic curve (AUC), calibration by the Hosmer-Lemeshow test, and clinical utility by decision curve analysis. Based on the regression coefficients of the multivariable logistic regression model, the coefficients were simplified into an simplified risk score, and patients were stratified into low-, intermediate- and high-risk groups by the tertiles of the total score in the training set, missing values imputed separately within each set and all model parameters derived from the training set. Results Twelve variables were selected by Lasso regression, and multivariable logistic regression identified Gender (OR = 2.12, 95% CI 1.41–3.21, P < 0.001), Age (per 1-year increase: OR = 1.03, 95% CI 1.02–1.05, P < 0.001) and Heart rate (per 1-beat/min increase: OR = 0.99, 95% CI 0.97–0.99, P = 0.045) as independent predictors of prevalent CCB at admission. The AUC was 0.68 (95% CI 0.63–0.74) and 0.70 (95% CI 0.62–0.78) in the training and internal validation sets, respectively, and the corresponding Hosmer-Lemeshow P values were 0.9676 and 0.7584.In the internal validation set, the calibration intercept was −0.04 (95% CI −0.35 to 0.28) and the calibration slope 1.12 (95% CI 0.61 to 1.63). The odds of CCB increased stepwise across the low-, intermediate- and high-risk strata in both sets (intermediate risk: OR 2.54 and 2.80; high risk: OR 4.73 and 6.56, respectively). Conclusion Female Gender, Age and Heart rate were independent predictors of prevalent CCB at admission in anti-SSA/Ro antibody-positive patients. A risk score based on these three predictors stratified patients into low-, intermediate- and high-risk groups, with a stepwise increase in the odds of CCB that was reproduced in the internal validation set. Discrimination was nevertheless modest and, pending external validation, the score should serve as an adjunctive tool for preliminary risk stratification rather than for individual prediction or diagnosis.

Frontiers in Cardiovascular MedicineVol. 13
Xinjiang Medical University (CN), First Affiliated Hospital of Xinjiang Medical University (CN), People's Hospital of Xinjiang Uygur Autonomous Region (CN)
Good health and well-being
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon